The next cycle was harder.
Dr. Shah had warned us that chemotherapy did not care whether a family had already reached its emotional quota.
Sophie developed mouth sores on the third day.
By the fourth, even water tasted wrong.
She pushed away a bowl of soup and said, “It tastes like pennies.”
Daniel tried it.
“It tastes like soup.”
“You have a defective tongue.”
“Possible.”
I expected her to laugh.
She didn’t.
She curled onto her side and closed her eyes.
That was how I learned the difference between Sophie being tired and Sophie being exhausted.
Tired Sophie complained.
Exhausted Sophie became quiet.
Dr. Shah adjusted her nausea medication.
The oncology dietitian brought six different drinks.
Sophie rejected five.
The sixth was a strawberry shake that looked like melted insulation.
She drank half.
We celebrated silently.
No applause.
No encouragement that turned every swallow into a performance.
We were learning.
Her hCG remained normal.
The brain lesion continued responding.
Those facts existed alongside the mouth sores, the bruises on her legs and the mornings when standing made her dizzy.
Good news did not cancel suffering.
Bad days did not cancel progress.
Daniel had returned to work part-time.
His employer let him handle most things remotely, which meant our dining room became a combination office, pharmacy, school desk and storage area for medical supplies.
He attended video meetings wearing a respectable shirt above the waist and pajama pants below.
Sophie discovered this.
She took photographs.
“Delete those.”
“No.”
“I am your father.”
“That’s why they’re valuable.”
She sent one to Eric.
Daniel stared at her.
“Betrayal.”
Sophie smiled.
There she was.
Eric had changed too, though less visibly.
He stopped arriving unannounced.
He asked before entering treatment discussions.
When he did not understand something, he asked instead of pretending.
Once, when Dr. Shah mentioned an elevated liver enzyme, Eric said, “I’m starting to panic. Tell me whether this is panic-worthy.”
Dr. Shah answered, “Not yet.”
He nodded.
“Okay.”
No secret investigation.
No late-night search.
No hidden phone.
It looked almost ordinary.
That made me realize how extraordinary ordinary behavior had become.
Agent Bell returned one Thursday carrying a list.
Not names.
Numbers.
Samuel’s final repository contained 4,812 biological samples linked to 731 individuals.
Some donors were adults.
Many had been children when samples were taken.
Consent documentation ranged from questionable to nonexistent.
“What happens now?”
“An independent ethics team is reviewing every record.”
“And the people?”
“We’re identifying them.”
“Will you tell everyone?”
“When we can verify what belongs to whom.”
Daniel asked, “What if somebody doesn’t want to know?”
Agent Bell nodded.
“That’s one of the problems.”
The question followed me for days.
We had spent weeks believing truth was always the antidote to secrecy.
But truth could also arrive like a weapon if someone had never asked for it.
A forty-year-old woman might learn that cells taken from her at age six still existed in a freezer.
A father might learn that his dead child’s tissue had been stored for decades.
Someone healthy might discover a biological alteration with uncertain consequences.
What right did we have to force that knowledge into their lives?
I asked Dr. Shah.
“We don’t,” she said.
“Then how do they make informed decisions?”
“By being offered information without being coerced into receiving all of it.”
“Is that possible?”
“It has to be.”
She explained that ethics teams were developing tiered notifications.
People could choose how much they wanted to know.
Whether samples existed.
Whether genetic alteration was suspected.
Whether clinically relevant findings had been identified.
Whether they wanted samples destroyed, returned where legally possible, or retained for ethically supervised research.
“Samuel would hate that.”
“What?”
“All the choices.”
Dr. Shah smiled faintly.
“Yes.”
Nathan participated only as a technical consultant.
He was not permitted access to identities.
That restriction bothered him at first.
“I could help identify exposure patterns.”
“You don’t need names for that,” Dr. Shah said.
“Some patterns depend on family relationships.”
“Then an independent team will provide de-identified relationships.”
Nathan started to argue.
Stopped.
“Right.”
I watched him learning boundaries one irritation at a time.
His criminal case was moving forward.
Federal prosecutors had added charges related to Westbrook, unauthorized gene intervention and obstruction.
His cooperation mattered.
His confession mattered.
His childhood mattered.
None erased Sophie.
When he asked to send her a letter, Agent Bell brought it to me unopened.
“What do you want me to do?”
I looked at the envelope.
“Ask Sophie.”
“She’s ten.”
“It’s addressed to her.”
Sophie wanted it.
She read slowly because Nathan’s handwriting was terrible.
Halfway through she looked up.
“He writes like a doctor.”
Daniel said, “That’s an insult to several professions.”
The letter did not ask forgiveness.
Nathan described what he had done in language Sophie could understand.
He admitted he had been afraid.
He admitted he had valued proof over her safety.
He said he was helping researchers understand the vectors, but that did not make what he did acceptable.
At the end:
You do not owe me an answer.
Sophie folded the letter.
“Good.”
“You want to reply?”
“No.”
“Okay.”
She placed it in the drawer beside Noah’s drawing.
Not thrown away.
Not treasured.
Simply kept.
That afternoon a woman named Rachel Kim contacted me through Agent Bell.
She had been one of Samuel’s early pediatric subjects.
Age seven at enrollment.
Now forty-six.
She wanted to meet.
I almost refused.
Then Agent Bell explained she had specifically requested me because Laura’s archive contained a letter with my mother’s name beside hers.
We met in a hospital conference room.
Rachel had short gray-streaked hair and the habit of rubbing her thumb against her wedding ring when nervous.
“I don’t remember Samuel.”
I waited.
“I remember needles.”
Her voice remained steady.
“I remember my mother telling me doctors were trying to make me stronger.”
“Did you know your samples still existed?”
“No.”
“Do you know what was done?”
“Only what the ethics team offered.”
She had chosen to receive the full report.
Samuel’s group administered an early immune-vector preparation.
No known germline integration.
No identified long-term disease.
Rachel had two healthy children.
“What do you want from me?”
She looked embarrassed.
“I don’t know.”
That answer felt familiar.
She took out a photocopy.
My mother’s handwriting.
Rachel’s initials appeared at the top.
R.K., AGE 7.
Below:
STOP DOSING. FEBRILE RESPONSE. PARENTS NOT INFORMED OF VECTOR CHANGE.
Laura had written the note.
Rachel looked at me.
“Did she stop it?”
“I don’t know.”
“Was she helping him?”
“Yes.”
The answer hurt to give.
“She was also trying to stop some things.”
Rachel nodded.
“That’s what they told me.”
“You don’t have to make her good because I’m her daughter.”
“I know.”
“And you don’t have to make her bad either.”
Rachel looked down.
“I spent two days trying to decide whether I should hate a woman who died before I knew her name.”
“What did you decide?”
“That I’m tired of strangers deciding what I should feel.”
I smiled.
“Sophie would like you.”
Rachel laughed.
Then she asked the question that had brought her.
“Are you letting them study your daughter’s samples?”
I hesitated.
“Some.”
“Why?”
“Because Sophie agreed.”
Rachel looked at me.
“She understands?”
“As much as a ten-year-old can.”
“And you’re comfortable with that?”
“No.”
That surprised her.
“I’m comfortable with the process.”
I explained.
Every research use was separate from treatment.
No experimental intervention.
Samples coded.
Independent oversight.
We could withdraw permission for future research.
Most importantly, Sophie could say no.
Rachel rubbed her ring.
“I want mine destroyed.”
“Then tell them.”
“What if destroying it prevents someone from learning something useful?”
There it was.
Samuel’s ghost.
Not the man.
The argument.
I leaned forward.
“Your body doesn’t owe science a useful ending.”
Rachel’s eyes filled.
I heard my mother somewhere inside the sentence.
Maybe Sophie too.
Rachel nodded.
“I needed someone to say that.”
The ethics team destroyed her stored samples two weeks later.
She sent me one message afterward.
DONE.
Nothing else.
Sophie’s next scan arrived the same day.
Dr. Shah placed the images side by side.
The brain lesion was barely recognizable compared with the first MRI.
Residual tissue remained.
“Scar?” I asked.
“Possibly. Possibly viable tumor. We’ll continue treatment and reassess.”
Sophie pointed at it.
“Kevin looks like a raisin.”
Daniel nodded.
“A deeply disappointing raisin.”
Her ovarian follow-up remained clear.
No evidence of Gertrude returning.
We allowed ourselves dinner from Sophie’s favorite noodle restaurant.
She ate four bites.
Then six.
Then announced she was done.
Nobody asked for seven.
Progress had become measured in strange units.
Cells.
Spoonfuls.
Steps.
Normal lab values.
Minutes without nausea.
The following morning Agent Bell called.
The independent repository team had discovered a group of samples separated from the others.
Thirty-one children.
All collected after Samuel supposedly ended pediatric intervention.
The dates ranged from eleven years ago to three years ago.
Nathan knew nothing about them.
Pierce claimed he knew nothing.
Margaret’s NorthStar records contained no corresponding shipments.
“Then who collected them?”
“We don’t know.”
Each sample was labeled with a symbol instead of initials.
A blue star inside a white circle.
I remembered the sticker on the black NorthStar SUV.
The symbol that had first connected Eric’s old employer to the fake clinic.
Agent Bell continued.
“The samples weren’t stored under Samuel’s project codes.”
“Whose codes?”
“A program called BLUEBIRD.”
My mother’s blue ceramic bird.
The clue she had used to preserve evidence.
I felt cold.
“Laura?”
“That’s what we’re trying to determine.”
The program began years after my mother died.
So Laura could not have run it.
But someone had taken the symbol associated with her evidence and built a new pediatric sample program around it.
Daniel looked at me.
“Samuel wasn’t the end.”
“No.”
Agent Bell corrected him.
“Maybe not.”
The thirty-one children were alive.
The newest sample had been collected three years earlier.
The repository contained addresses.
School records.
Medical histories.
One address was familiar.
Westbrook.
Not the fake clinic.
The neighborhood where Dr. Lena Ortiz lived.
Click here to continue reading: PART 18: The Bluebird Program Looked Like Another Secret Experiment Until Dr. Ortiz Revealed Why Thirty-One Children Had Been Hidden From Samuel Instead
A Routine Visit Turned Into an Accusation When My Ten-Year-Old Daughter’s Blood Test Showed Something No One Could Explain
Part 17 of 23
One Comment on “PART 17 – Sophie’s Treatment Was Finally Working, but the Families Behind Samuel’s Forgotten Samples Brought a Question No Laboratory Could Answer for Them”